Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

Abstract Patient‐reported quality‐of‐life (QoL) and carer impacts are not reported after leucine‐rich glioma‐inactivated 1‐antibody encephalitis (LGI1‐Ab‐E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to...

Full description

Bibliographic Details
Main Authors: Sophie N. M. Binks, Michele Veldsman, Adam E. Handel, Saiju Jacob, Paul Maddison, Jan Coebergh, Sophia Michael, Sudarshini Ramanathan, Ava Easton, Mette Scheller Nissen, Maria Isabel Leite, David Okai, Morten Blaabjerg, Masud Husain, Sarosh R. Irani
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.52006

Internet

https://doi.org/10.1002/acn3.52006

Similar Items